CCWM
WST icon

Cassaday & Co Wealth Management’s West Pharmaceutical WST Stock Holding History

Cassaday & Co Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359 Hold
1
– – ﹤0.01% 1165
2026
Q1 		$251 Buy
+1
New +$249 ﹤0.01% 1247

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Cassaday & Co Wealth Management's WST Position: Q2 2026 in Review

Cassaday & Co Wealth Management held its West Pharmaceutical (WST) position steady in Q2 2026 at 1 share worth $359. The position accounts for ﹤0.01% of the portfolio, ranked #1165.

Cassaday & Co Wealth Management first reported a position in WST in Q1 2026 and has held it in 2 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Cassaday & Co Wealth Management held 1 share of West Pharmaceutical worth $359 as of Q2 2026.
  • Cassaday & Co Wealth Management left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q2 2026, its #1165 holding.
  • Cassaday & Co Wealth Management first reported a position in West Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.